Atrasentan in Treating Patients With Progressive or Recurrent Malignant Glioma

Clinical trial NCT00017264 · COMPLETED

Trial details

NCT number: NCT00017264
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2002-06-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.